The Claim
Between 1965 and 2017, low- and middle-income countries contributed fewer than 10% of all randomized controlled trial-related articles published in high-impact medical journals, despite accounting for over 80% of the global population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Between 1965 and 2017, countries with lower and middle incomes produced less than 10% of randomized controlled trial articles in top medical journals, even though they made up more than 80% of the world's population.
See the scientific wording
Low- and middle-income countries contributed fewer than 10% of all RCT-related articles in high-impact medical journals between 1965 and 2017, despite representing over 80% of the global population, indicating severe inequity in global clinical research production.
This claim describes a pattern of research publication, not a biological process. No biological events occur in the body that produce this outcome.
What the research says
1 studyEven though most people in the world live in poorer countries, almost all the big medical studies published in top journals came from rich Western countries like the U.S. and U.K., meaning poorer countries had very little say in shaping global medical knowledge.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.